Neuromodulation to Facilitate the Effect of Ketamine
Information source: The Neuroscience Center, LLC
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Depression; Chronic Pain; Substance Abuse
Intervention: co-administration of TMS and infused ketamine (Other)
Phase: N/A
Status: Completed
Sponsored by: The Neuroscience Center, LLC Official(s) and/or principal investigator(s):
Steven R Devore Best, M.D., Principal Investigator, Affiliation: The Neuroscience Center
Summary
application of external neuromodulation along with ketamine infusion.
Clinical Details
Official title: Treatment of Thalamocortical Dysrhythmia Using External Neuromodulation to Facilitate the Therapeutic Effect of Ketamine.
Study design: Observational Model: Case Control, Time Perspective: Retrospective
Primary outcome: Global Assessment of Function in DSM-4R
Detailed description:
apply TMS concurrent with ketamine infusion in order to increase the likliehood & strength
of therapeutic benefit
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- chronically ill,
- treatment-resistant
Exclusion Criteria:
- active psychosis
Locations and Contacts
The Neuroscience Center, Deerfield, Illinois 60015, United States
Additional Information
Starting date: January 2011
Last updated: March 20, 2013
|
